DMCC SPECIALITY CHEMICALS LIMITED has informed the Exchange regarding Board meeting held on August 07, 2025.
DMCC · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
DMCC Speciality Chemicals Limited held its board meeting on August 7, 2025 and approved the unaudited standalone and consolidated financial results for the quarter ended June 30, 2025 (Q1 FY26). On a standalone basis, net sales came in at Rs. 12,702.32 lakhs, up sharply from Rs. 8,531.81 lakhs in the same quarter last year. Net profit jumped to Rs. 775.31 lakhs (vs Rs. 138.58 lakhs in Q1 FY25), with basic EPS rising to Rs. 3.11 from Rs. 0.56. The board also re-appointed Dr. Janaki Ashwin Patwardhan as Non-Executive Independent Director for a second five-year term starting May 21, 2026, subject to shareholder approval. The statutory auditors issued an unmodified limited review opinion on the results.
Strong year-on-year growth in both revenue (~49%) and profit (~5.6x) for Q1 FY26 is a positive earnings signal and could support short-term sentiment. The director re-appointment is routine governance and unlikely to move the stock on its own.